Skip to main content
. 2021 Jun 18;36(Suppl 2):ii3–ii9. doi: 10.1093/ndt/gfab045

FIGURE 1.

FIGURE 1

TNFR1, TNFR2 and KIM-1 were strongly associated with renal outcomes in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) and VA NEPHRON-D (Veterans Affairs Nephropathy in Diabetes) trials involving patients with type 2 diabetes at early and advanced stages of CKD [24].